(HealthDay)—Worse atopic dermatitis (AD) severity is associated with increased odds of learning disorders in pediatric patients, according to a study published online April 14 in JAMA Dermatology.
Nerve stimulation reduces pain and opioid use after orthopedic surgery
A technique called percutaneous peripheral nerve stimulation yields “impressive” reductions in pain scores and opioid use during the first week after common orthopedic surgery procedures, concludes a randomized clinical trial published Online First in Anesthesiology, the official peer-reviewed journal of the American Society of Anesthesiologists (ASA), today.
Habitat and species loss leaves just 3% of world’s land ecosystems intact, study suggests
Just under 3% of the world’s land remains ecologically intact, with undisturbed habitat and minimal loss of its original animal species, a new study suggests.
Chicago police body camera footage to be released in fatal shooting of 13-year-old boy
The Chicago Civilian Office of Police Accountability will release body camera footage on Thursday from the fatal police shooting of 13-year-old Adam Toledo last month.
Iran Talks Resume, Gingerly, After Attack on Nuclear Site
Another round of Vienna talks on reviving the 2015 nuclear accord is considered to be positive despite an apparent Israeli attack on Iran’s Natanz nuclear facility.
The best horror games of all time
There’s nothing quite like a good spooky game, and thankfully, the genre has seen a boom in popularity in recent memory. These are the best horror games ever.
Iran to purchase 60 million COVID-19 vaccines from Russia
Iran has finalized a deal with Russia to purchase 60 million doses of Sputnik V coronavirus vaccine, the state-run IRNA news agency reported Thursday.
Nine ways to make video calls on your TV
Video calling is at an all-time high in terms of popularity, but doing it from the best screen in the house is still surprisingly hard. Here’s how to do it.
Study finds link between racial factors and likelihood of getting proven diabetes treatment
A new study from researchers at the Perelman School of Medicine at the University of Pennsylvania found significant disparities in the use of sodium-glucose cotransporter 2 (SGLT2) inhibitors, a class of drugs proven to treat type 2 diabetes, with usage remaining low with Black, Asian, and lower-income groups despite an increase in overall usage for …